Skip to main content
SpringerLink
Log in

Streptogramins may be useful in the treatment of resistant Gram-positive infections

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Service RF. Antibiotics that resist resistance. Science 1995 Nov 3; 270: 724–7

    Article  PubMed  CAS  Google Scholar 

  2. Griswold MW, Lomaestro BM, Briceland LL. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. Am J Health-Syst Pharm 1996 Sep 1; 53: 2045–53

    PubMed  CAS  Google Scholar 

  3. Fuller RE, Drew RH, Perfect J. Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin. Pharmacotherapy 1996; 16(4): 584–92

    PubMed  CAS  Google Scholar 

  4. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989–1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597–9

    Google Scholar 

  5. Pechère J-C. Streptogramins: a unique class of antibiotics. Drugs 1996; 51 Suppl. 1: 13–9

    Article  PubMed  Google Scholar 

  6. Hamilton-Miller JMT. From foreign pharmacopoeias: ‘new’ antibiotics from old? J Antimicrob Chemother 1991; 27: 702–5

    Article  PubMed  CAS  Google Scholar 

  7. Bryson HM, Spencer CM. Quinupristin-Dalfopristin. Drugs 1996; 52(3): 406–15

    Article  PubMed  CAS  Google Scholar 

  8. Kostman JR, Fekete T, Woodwell J, et al. Emergence of macrolide-streptogramin resistance during therapy of Staphylococcus aureus bacteremia with quinupristin/dalfopristin (RP59500). Clin Infect Dis 1995 Sep; 21: 746

    Google Scholar 

  9. First reports of Synercid resistance. Scrip 1996 Mar 26; (2114): 19

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Streptogramins may be useful in the treatment of resistant Gram-positive infections. Drugs Ther. Perspect 8, 6–8 (1996). https://doi.org/10.2165/00042310-199608120-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199608120-00003

Keywords

Search

Navigation